Arthur Tzianabos, Director at Stoke Therapeutics, Inc. (STOK), sold 10,000 shares at $60.67 ($607K) on 2021-02-19, disclosed to the SEC on 2021-02-23.
Open-market sale of $607k STOK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FIXX | SELL | 2024-02-15 | $7K | — | Filing → |
| FIXX | SELL | 2023-01-11 | $15K | — | Filing → |
| FIXX | SELL | 2022-01-12 | $20K | — | Filing → |